NASDAQ •
Healthcare •
Health Information Services •
Quote as of 05/08/2026 15:00
Company Profile
IndustryHealth Information Services
SectorHealthcare
ExchangeNASDAQ
Market Capitalization266.82 mln
Float9.94 mln
Earnings Date08/27/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.02
Caution advised
Relative Strength
19
/ 100
Significantly lagging
Debt / Equity
0.18
Very low leverage
ROE
-52.43
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Carlsmed is a California-based medical technology company that uses artificial intelligence to create personalized solutions for spinal fusion surgery. Its core product, the aprevo platform, combines smart surgical planning software with custom-built implants shaped to fit each patient's unique anatomy. The software draws on real-world outcome data to help surgeons make better decisions before and during procedures. Founded in 2018 and headquartered in Carlsbad, the company is already selling its technology commercially.
